Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Precision medicine in hemato-oncology - treatment of refractory multiple myeloma with massive extramedullary involvement using BRAF/ MEK inhibitors.
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2025
Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
New developments in intracranial stereotactic radiotherapy for metastases.
Clinical oncology (Royal College of Radiologists (Great Britain))·2015
Achieving the relocation accuracy of stereotactic frame-based cranial radiotherapy in a three-point thermoplastic shell.
Clinical oncology (Royal College of Radiologists (Great Britain))·2012
Twenty-five years survival of primary central nervous system lymphomas treated with the C5R regimen.
European journal of cancer (Oxford, England : 1990)·2026
Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.
European journal of cancer (Oxford, England : 1990)·2026
Development of an age specific EORTC questionnaire to assess the health-related quality of life (HRQOL) of children with cancer aged 8-14 years - a mixed-methods content elicitation phase I & II EORTC QLG study.
European journal of cancer (Oxford, England : 1990)·2026
Lenvatinib plus pembrolizumab for the treatment of patients with non-BRAF mutated anaplastic thyroid cancer: A single center, phase 2 clinical trial.
European journal of cancer (Oxford, England : 1990)·2026
Older adults with resectable gastric cancer undergoing perioperative chemotherapy or preoperative chemoradiotherapy plus perioperative chemotherapy: A secondary analysis of the AGITG TOPGEAR phase III trial.
European journal of cancer (Oxford, England : 1990)·2026
Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe.
European journal of cancer (Oxford, England : 1990)·2026